Liposomes are effective nanocarriers due to their ability to deliver encapsulated drugs to diseased cells. Nevertheless,l iposome delivery would be improved by enhancing the ability to control the releaseo fc ontentsa tt he target site. While various stimuli have been explored for triggering liposomer elease, enzymesp rovide excellent targets duet o their common overexpression in diseased cells. We present a generala pproacht oe nzyme-responsivel iposomes exploiting targets that are commonly aberrant in disease, including esterases, phosphatases,a nd b-galactosidases. Responsive lipids correlating with each enzyme family were designed and synthesized bearing an enzymes ubstratem oiety attached via aself-immolating linker to anon-bilayer lipid scaffold , such that enzymatic hydrolysis triggersl ipid decomposition to disrupt membrane integritya nd releasec ontents. Liposomed ye leakage assays demonstrated that each enzyme-responsive liposome yieldeds ignificant content release upon enzymatic treatment compared to minimal release in controls. Results also showedt hat fine-tuning liposome compositionw as critical for controlling release. DLS analysiss howedp article size increases in the cases of esterase-and b-galactosidase-responsive lipids, supportinga lterations to membrane properties. These resultss howcase an effectivem odulars trategy that can be tailored to target different enzymes,p roviding ap romising new avenue for advancing liposomal drug delivery.